Medical Problems in Pregnancy Flashcards

1
Q

Which couples are at high risk of conceiving a child with a NTD?

A
  • Either partner has a NTD, they have had a previous pregnancy affected by a NTD, or they have a family hx of NTD.
  • The woman is taking anti-epileptic medication.
  • The woman has coeliac disease or other malabsorption state, diabetes mellitus, sickle-cell anaemia, or thalassaemia.
  • The woman is obese (BMI >30).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the daily dosages of folic acid which should be taken by pregnant women at normal risk of neural tube defects?

And those at high risk?

A
  • Normal risk for a NTD - folic acid 400µg daily, to continue until the 12th week of pragnancy.
  • High risk of a NTD - folic acid 5mg daily, to continue until the 12th week of pregnancy.
  • Women with sickle cell disease, thalassaemia, or thalassaemia trait should take folic acid 5mg daily throughout pregnancy.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What issues must be addressed in a pre-conception discussion with a woman who has a pre-existing medical condition?

A
  • Healthy weight
  • Folic acid
  • Quit smoking
  • Alcohol and drugs
  • Nutrition and anaemia
  • Encourage women to continue to use contraception and their regular medication until they have had a full review with their specialised team, as well as other routine preconceptual care.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the common pre-existing conditions which cause concern when a woman becomes pregnant?

A
  • Anaemia
  • Hypertension
  • Endocrine disorders - thyroid disease, diabetes
  • Psychotic disorders
  • Epilepsy
  • Autoimmune diseases
  • Heart disease
  • Coagulation disorders
  • Renal diseases
  • Respiratory diseases
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How is asthma managed in pregnancy?

A
  • There is little need for modification of treatment in pregnancy.
  • The risk of uncontrolled asthma outweighs and risk from medication.
  • Steroids should be used as needed in the usual way and not withheld due to pregnancy.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the management of CF in pregnancy.

A
  • Autosomal recessive
  • CF team speak to every woman diagnosed with CF as soon as she turns 16 about which kind of contraception she is using and counsel her on the risk of offspring having CF; partner is also screened to check if they are a carrier of CF.
  • Preconception counselling and planned pregnancy:
    • Woman must be reminded of the importance of continuing physiotherapy throughout and beyond pregnancy (if neglected, lungs will clog).
    • Can have IVF and use a donor to prevent risk of baby having CF.
    • Maternal nutrition, control of pulmonary infection and avoidance of hypoxia and fetal surveillance.
  • MDT management
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe the concerns and management in a woman who is pregnant and epileptic.

A
  • Majority of women have diagnosis before pregnancy.
    • 1/3 improve; 1/3 deteriorate; 1/3 remain the same.
  • In general, fetus is resistant to short episodes of hypoxia but status epilepticus is dangerous to both mother and fetus.
  • Main concern - teratogenic potential of the anticonvulsant medications (sodium valproate = high risk).
  • Lamotrigine and Levetiracetam are commonly used and are safe in pregnancy.
  • All women with a hx. of epilepsy should take high dose folic acid - 5mg / day.
  • Planned pregnancy and discussion with neurologist is recommended.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe the management of a woman with diabetes who is considering pregnancy.

A
  • Planned pregnancy recommended.
  • HbA1c should be kept below 48 mmol/mol to reduce risk of congenital malformation.
  • Women with HbA1c of above 86 mmol/mol should avoid pregnancy until better control has been established.
  • Blood glucose targets, monitoring and control should be discussed prior to pregnancy.
  • Individualised targets for self-monitoring of blood glucose should be agreed, taking into account the risk of hypoglycaemia.
  • Metformin can be used as an adjunct or alternative to insulin in those with T2DM but other oral hypoglyaemics should be discontinued prior to pregnancy.
  • Many with T2DM will be converted to insulin during this period.
  • Good glycaemic control before conception and throughout pregnancy will reduce, but not eliminate the risk of miscarriage, congenital malformation, stillbirth and neonatal death.
  • Structured educational programmes should be offered where women have not previously attended one.
  • Provide advice on diet, exercise and weight loss (prior to pregnancy).
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the complications which occur in pregnancy secondary to DM?

Describe how to manage these.

A
  • Check for retinal and renal complications.
  • Retinal screening should be done unless it has been done in the previous 6 months.
  • Refer to nephrology where eGFR <45 mL/min, creatinine is abnormal or the UACR >30 mg/mmol.
  • Review concurrent medication and stop ACE-Is, ARBs and statins.
  • Check for co-existing thyroid disease in those with T1DM (TSH, free T4 and thyroid peroxidase antibodies).
  • Treat as high risk for NTD with a dose of 5mg folic acid pre-conception and up to 12 weeks.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe how to manage thyroid disorders during pregnancy.

A
  • Hypothyroidism common (1%).
    • Increase the thyroxine dose by 25µg at positive pregnancy test.
      • Because of changes in maternal physiology.
    • Repeat TFTs every 12 weeks / trimester (should be 2-4).
    • Postnatally 6-12 weeks repeat TFT.
  • Subclinical hypothyroidism
    • Should commence treatment and be referred to an endocrinologist if contemplating pregnancy.
  • Hyperthyroidism - Grave’s disease
    • Specialist review
    • Anti-thyroid treatment
    • Fetal monitoring
  • The use of radioactive iodine is contraindicated in pregnancy.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Describe the management of hypertension in pregnancy.

A
  • Increases the risk of pre-eclampsia during pregnancy.
  • It also increases the risk of placental abruption and neonatal morbidity and mortality.
  • ACE-Is and ARBs are contraindicated in pregnancy, so ideally should be changed prior to pregnancy.
  • If the woman becomes pregnant, substitute with an alternative agent suitable for use during pregnancy.
  • Labetalol is usually first-line.
  • Drugs of choice are methyldopa, beta-blockers (labetalol, propanolol, metoprolol) and nifedipine.
  • If uncomplicated hypertension, target BP will be below 140/90mmHg.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the management of cardiac disease in pregnancy.

A
  • MDT
  • All women with congenital or acquired heart disease should discuss future pregnancies with a cardiologist.
    • Advise women to continue contraception until this discussion has taken place.
  • The risk of fetus having congenital heart disease is higher if mother has CHD.
  • Statins are contraindicated in pregnancy and should be stopped prior to conception.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the cardiac abnormalities with minimal risk (<1%) to maternal mortality?

A
  • Atrial septal defect
  • Ventricular septal defect
  • Patent ductus arteriosus - corrected and uncorrected
  • Corrected Fallot’s tetralogy
  • Benign arrhythmias
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the cardiac abnormalities which carry high risk of maternal mortality?

A
  • Primary pulmonary hypertension
  • Eisenmenger’s syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Describe puerperal cardiomyopathy in pregnancy.

A
  • Usually occurs from 24 weeks gestation to 6/12 postnatally.
  • Risk factors:
    • Maternal age
    • Hypertension
    • Multiparity
    • Multiple pregnancy
  • Symptoms:
    • SOB
    • Poor exercise tolerance
    • Palpitations
    • Peripheral and pulmonary oedema
  • Prognosis is variable - difficult to predict so is potentially fatal.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe the management of inflammatory bowel disease during pregnancy.

A
  • Ulcerative colitis
  • Crohn’s disease
  • Nonspecific colitis
  • Proctitis
  • Crohn’s do better than ulcerative colitis as they have less relapses.
  • 5mg folic acid / day throughout pregnancy (because it is malabsorption disease).
  • Nutrition
  • Most of the medications can be continued throughout the pregnancy.
  • MDT management
  • Immunomodulators infusions are stopped by 24 weeks - do not want to interrupt neonatal vaccination.
17
Q

Which autoimmune diseases are affected by pregnancy?

How are they managed?

A
  • SLE - systemic lupus erythematosus (connective tissue disorder)
    • Affects multiple systems
    • Flare-ups in pregnancy
    • Most treatments can be continued
  • Rheumatoid arthrities
    • 75% improvement in symptoms, but 90% who experience remission suffer postpartum exacerbations.
    • Concern - safety of medication used in the treatment.
    • Disease-modifying agents - chlorambucil, gold salts and cyclophosphamide are contraindicated in pregnancy.
18
Q

Describe the presentation of antiphospholipid syndrome, its consequences during pregnancy and its management.

A
  • History of thrombosis.
  • Recurrent pregnancy loss.
  • Presence of antiphospholipid antibodies - aCL, LA.
  • Increased pregnancy loss, thromboembolic disease and stroke.
  • Early onset pre-eclampsia, IUGR
  • Aspirin
  • LMWH
19
Q

Describe autoimmune thrombocytopaenia and its effect during pregnancy.

A
  • 1:1000 pregnancies
  • Low maternal platelet count in the first half of pregnancy.
  • Regular monitoring of platelet count.
  • Risk of haemorrhage to the mother.
  • Small risk - fetus may have low platelet count.
20
Q

What are the coagulation disorders affected by pregnancy and how are they managed?

A
  • Pregnancy is associated with changes in all aspects of the hemostatic mechanism - hypercoagulable state.
  • Haemophilias are an X-linked recessive disorder. Plan genetic counselling.
  • Von Willebrand’s disease is a genetic defect in the short arm of chromosome 12. There are 3 types.
21
Q

Describe the management of sickle cell disease in association with pregnancy.

A
  • Inherited abnormality of Hb synthesis.
  • Genetic counselling and screening of partner.
  • MDT - refer to both haematologist and geneticist.
  • Folic acid - 5mg throughout pregnancy (to aid haematopoiesis).
  • Clinical presentation:
    • Haemolytic anaemia and vaso-occlusive symptoms.
  • Sickle cell crisis.
  • Women who are carriers should be treated as in a normal pregnancy and should receive the normal 400µg dose of folic acid.
22
Q

Describe the management of thalassaemia in association with pregnancy.

A
  • Most common genetic blood disorder.
  • Reduced rate of globin synthesis.
  • Genetic counselling and screening of partner.
  • Folate supplementation of 5mg throughout the pregnancy.
  • Refer to haematologist and geneticist.
23
Q

Define and describe mild renal deficiency.

What are the effects on pregnancy.

A
  • Plasma creatinine <125 µmol/L without hypertension and proteinuria of 1 g/day.
  • There is little evidence that pregnancy accelerates renal disorder.
24
Q

Define and describe moderate renal deficiency.

What are the effects on pregnancy.

A
  • Plasma creatinine levels of 125-250 µmol/L.
  • High risk of uncontrolled hypertension and increase in proteinuria - poor obstetric outcome.
25
Q

Define and describe severe renal disease.

What are the effects on pregnancy.

A
  • Plasma creatinine >250 µmol/L
  • Marked anaemia, hypertension, retinopathy or heavy proteinuria.
  • Should avoid pregnancy, fetal loss is ~60%.
  • BP monitoring
  • UACR
  • Uric acid and platelet levels
  • Women on dialysis are prone to complications of fluid-overload, hypertension, pre-eclampsia and polyhydraminos.
  • 50% increase in dialysis may be needed during pregnancy.
26
Q

What are the risks associated with renal disease in pregnancy?

How are they monitored?

A
  • IUGR
  • Prematurity
  • Deterioration in maternal renal function
  • BP monitoring
  • Urine ACR
  • Uric acid and platelet levels
  • Women with progressive renal disease may be advised to complete pregnancies while renal function remains relatively good.
27
Q

Describe VTE in pregnancy.

A
  • Hx. of DVT or PE or an abnormal thrombopilia screen should be referred to a speciaist for advice.
  • Thromboprophylaxis may be needed.
  • Warfarin is teratogenic and therefore contraindicated in pregnancy and must be stopped or replaced by heparin.
  • DOACs (dabigatran, apixaban and rivaroxaban) also not safe in pregnancy and should be replaced.
28
Q

Describe the management of a patient with depression who is considering pregnancy.

A
  • Risk assessment and individualised treatment.
  • Pre-conception discussion in severe cases.
  • Ideally, medication should be stopped prior to pregnancy but if this is not possible, the antidepressants with the lowest risk should be used.
  • Seek specialist advice in women with severe depression who are planning pregnancy.
  • For mild depression, consider gradual withdrawl of antidepressants, and, if need be, starting psychological therapy or self-help measures.
29
Q

Describe the use of anti-depressants in pregnancy.

A
  • Evidence is limited on safety of anti-depressants.
  • No risk has been demonstrated with tricyclic antidepressants.
  • SSRIs suggest possible risks of malformations with their use in the first trimester, and a possible withdrawl effect and (rarely) pulmonary hypertension in the newborn when used later in pregnancy.
  • Mirtazapine and Venlafaxine (most commonly used) have not been found to be associated with congenital malformations (pretty safe). There are potential risks of neonatal withdrawl.
  • Sudden withdrawl of an antidepressant in a woman with a hx. of severe depression may cause more harm than the potential risk of the medication.
30
Q

Describe the management of bipolar disorder and schizophrenia during pregnancy.

A
  • Preconception counselling and review of medication.
    • Advise women to continue contraception until this has occurred.
  • Medication may adversely affect pregnancy outcome and need changing - lithium, sodium valproate.
  • Some of the medication used may adversely affect fertility.
  • 50% risk of puerperal psychosis.
  • Don’t stop the medication abruptly because woman is pregnant. Can cause severe symptoms.
  • Go to the BNF and find out what is safe.
  • Have the discussion!
31
Q

Under which circumstances is genetic screening appropriate?

For which conditions?

A
  • Genetic screening is advised for couples planning pregnancy who have personal or family hx. of inherited genetic disorders, or who have had a previous pregnancy affected.
  • Conditions:
    • Huntington’s disease
    • Achondroplasia
    • Adult polycystic disease
    • Marfan’s syndrome
    • Tuberous sclerosis
    • Fragile X syndrome
    • Spinal muscular atrophy
    • Sickle cell disease
    • Tay-Sachs disease
    • Friedreich’s ataxia
    • Congenital adrenal hyperplasia
    • Glucose-6-phosphate dehydrogenase deficiency
    • Haemophilias A and B
    • Duchenne muscular dystrophy